Log in to search using one of your social media accounts:

Medscape Hematology-Oncology Headlines Medscape Hematology-Oncology Headlines RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prostate Cancer Diagnoses Fall as Use of PSA Test Declines Prostate Cancer Diagnoses Fall as Use of PSA Test Declines
Incidence rates of prostate cancer in the US are dropping, reflecting the declining use of the PSA test, but this leaves a huge amount undetected, warn experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EPA Data Reveal Ties Between Environment, Cancer Rates EPA Data Reveal Ties Between Environment, Cancer Rates
New research using Environmental Protection Agency data shows that the overall environmental quality of a geographic location is associated with cancer incidence.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Untreated Breast Cancers Do Not Spontaneously Vanish Untreated Breast Cancers Do Not Spontaneously Vanish
Contrary to some suggestions that have been made in recent years, untreated breast cancers do not regress or disappear if left untreated.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Avelumab: Another Immunotherapy for Bladder Cancer Avelumab: Another Immunotherapy for Bladder Cancer
Avelumab has been approved in the US for second-line use in urothelial cancer, making it the fourth immunotherapy with this indication.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

G-CSF Use in Small Cell Lung Cancer: New Data'Comforting'G-CSF Use in Small Cell Lung Cancer: New Data'Comforting '
Although patients with SCLC given granulocyte colony-stimulating factors during chemo-radiotherapy had an increased risk for hematologic complications, the drugs can be used safely, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Questions Over'Flu Jab' in Lung Cancer Patients on PD Inhibitors Questions Over'Flu Jab' in Lung Cancer Patients on PD Inhibitors
Patients with cancer receiving immune checkpoint inhibitors could be at increased risk for adverse events compared with the general population if they are given a yearly flu jab, say Swiss researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

PD-Inhibitor Benefits'Continue Beyond Progression' in NSCLC PD-Inhibitor Benefits'Continue Beyond Progression' in NSCLC
Non-small cell lung cancer patients can benefit from immunotherapy even after progression, from both drug continuance and the ongoing effect of prior treatment on salvage therapy, reveal two studies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

European Lung Cancer Conference (ELCC) 2017 European Lung Cancer Conference (ELCC) 2017
Read clinically focused news coverage of key developments from ELCC 2017.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Conference Coverage Source Type: news

Do Women Need Lung Cancer Screening Less Often Than Men? Do Women Need Lung Cancer Screening Less Often Than Men?
Women could undergo low-dose computed tomography screening for lung cancer as little as once every 3 years vs annual screening in men, suggests a retrospective analysis of screening data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO's Plan to Encourage Diversity in Oncology Workforce ASCO's Plan to Encourage Diversity in Oncology Workforce
ASCO's new strategic plan aims to close the diversity gap between oncologists, patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Survival Improves in mRCC With Surgical Metastasectomy Survival Improves in mRCC With Surgical Metastasectomy
Patients with metastatic renal cell carcinoma who had complete surgical metastasectomy have better survival outcomes than patients with no resection or incomplete resection of metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Biomarker Signals Poor Response in Prostate Cancer New Biomarker Signals Poor Response in Prostate Cancer
A new test identifies men with castration-resistant prostate cancer who have a poorer response to abiraterone and enzalutamide.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Standard of Care for EGFR Mutation-Positive Advanced NSCLC New Standard of Care for EGFR Mutation-Positive Advanced NSCLC
Dr Jack West talks about the new role of osimertinib for NSCLC patients with EGFR mutation-positive acquired resistance.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news

Found: Key Driver of Lung Cancer Evolution and Relapse Found: Key Driver of Lung Cancer Evolution and Relapse
The discovery of unstable chromosomes as the key driver in lung cancer also shows which patients relapse long before this can be seen with imaging.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Plain Packaging on Cigarette Packs May Cut Smoking Rates Plain Packaging on Cigarette Packs May Cut Smoking Rates
A ban on branded cigarette packets, similar to that introduced in Australia, could help reduce tobacco consumption by reducing the appeal of smoking, a systematic data review suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Unique' DCIS Study: Double Mastectomy Not Needed'Unique' DCIS Study: Double Mastectomy Not Needed
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Europe Approves Nivolumab for Head and Neck Cancer Europe Approves Nivolumab for Head and Neck Cancer
It's the first drug approved in this setting in Europe in more than a decade.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves Durvalumab (Imfinzi) for Urothelial Cancer FDA Approves Durvalumab (Imfinzi) for Urothelial Cancer
It's an accelerated approval for patients with urothelial carcinoma, which is, most commonly, a type of bladder cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves First New Drug for AML Since 1990 FDA Approves First New Drug for AML Since 1990
Midostaurin is indicated for the treatment of patients with newly diagnosed acute myeloid leukemia who have the FLT3 genetic mutation.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Breast Surgeon Found Guilty of'Wounding With Intent'Breast Surgeon Found Guilty of'Wounding With Intent '
After years of questions over his surgery on breast cancer patients, a criminal court has found Ian Paterson guilty of'wounding with intent. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First New Drug for Liver Cancer in a Decade: Regorafenib First New Drug for Liver Cancer in a Decade: Regorafenib
The FDA has approved an expanded indication for regorafenib to include hepatocellular carcinoma, making it the first drug to be approved for this cancer in a decade.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Dramatic Jump in Incidence of NETs Over Past 4 Decades Dramatic Jump in Incidence of NETs Over Past 4 Decades
The incidence of neuroendocrine tumors (NETs) has increased dramatically over the past 4 decades, but the rise may be due to improved diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Renowned Neurosurgeon on Assisted Dying and His'Suicide Kit'Renowned Neurosurgeon on Assisted Dying and His'Suicide Kit '
Releasing a second memoir of his experiences resecting brain tumors, Henry Marsh, FRCS, also talks about assisted dying and his own suicide kit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Troubles of the Billionaire'Moonshot' Doctor Troubles of the Billionaire'Moonshot' Doctor
Only months after being in the spotlight as a potential player in the Trump administration, a wealthy doctor is beset by a rash of controversiesMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Issues Guideline on Castrate-Resistant Prostate Cancer ASCO Issues Guideline on Castrate-Resistant Prostate Cancer
The new document, a provisional clinical opinion, offers guidelines for treating chemotherapy-naive men who develop castrate-resistant prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Takes Action Against'Bogus Cancer Cures'FDA Takes Action Against'Bogus Cancer Cures '
The FDA has sent warning letters to 14 companies that are'peddling bogus cancer cures'and are exploiting the cancer patients'desperation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Many Men Have No Discussion of Pros and Cons Before PSA Test Many Men Have No Discussion of Pros and Cons Before PSA Test
A national survey shows that less than one third of men are discussing the pros and cons of prostate-specific antigen testing with their healthcare provider before undergoing screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe Biosimilar Rutiximabs, and Inotuzumab, Coming to Europe
Two biosimilar rituximab products have been recommended for approval in Europe, as has inotuzumab ozogamicin for acute lymphoblastic leukemia.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Possibility of'Cure' for Metastatic Prostate Cancer Possibility of'Cure' for Metastatic Prostate Cancer
A small study in 20 men with early-stage extrapelvic and bone metastases shows that aggressive multimodal therapy'can eliminate detectable disease. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASTRO Releases First Guidelines for Oropharyngeal Cancer ASTRO Releases First Guidelines for Oropharyngeal Cancer
ASTRO releases its first guidelines for the management of oropharyngeal cancer but purposefully avoids distinguishing between HPV-positive and -negative disease despite differences in prognosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Strategies to Curb Drug Costs Affect Patient Care, Says ASCO Strategies to Curb Drug Costs Affect Patient Care, Says ASCO
Current utilization management policies used by health insurance companies to control drug costs may negatively affect patients with cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Brazil's Phospho Cancer Cure Frenzy: A Cautionary Tale Brazil's Phospho Cancer Cure Frenzy: A Cautionary Tale
Brazil's tale of a'miracle cancer pill'showcases how a mix of academic carelessness, political opportunism, and mistrust of science can turn into an explosive situation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Patients Vary Widely on Adjuvant Chemo -- Critical to Ask Patients Vary Widely on Adjuvant Chemo -- Critical to Ask
A new study finds that patients with early breast cancer differ with regard to their preferences for adjuvant chemotherapy; some want it, some do not, regardless of survival benefit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 19, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Further Immortalization of Henrietta Lacks The Further Immortalization of Henrietta Lacks
From her tumor cells to her life story as a woman, mother, and guiding light, Henrietta Lacks was extraordinary. She is the subject of a new movie.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Atezolizumab for Urothelial Cancer, Now Also First-Line Atezolizumab for Urothelial Cancer, Now Also First-Line
Already approved for use in metastatic urothelial carcer, the immunotherapy atezolizumab (Tencentriq, Genentech) can now be used as a first-line treatment.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Really, Men With Prostate Cancer Do Yoga Really, Men With Prostate Cancer Do Yoga
In a first-of-a-kind study, patients with prostate cancer who did yoga during radiotherapy reported less fatigue and better sexual and urinary function than those who didn ’ t.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Destroy Them: One Way to Up Price of Generic Cancer Drugs Destroy Them: One Way to Up Price of Generic Cancer Drugs
In the midst of a dispute with health authorities in Spain, an Aspen Pharmacare executive proposed the idea of destroying generic cancer drugs.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Drops Prescriber Training for ESAs in Chemo Patients FDA Drops Prescriber Training for ESAs in Chemo Patients
The agency concluded that clinicians have a better handle on prescribing the erythropoiesis-stimulating agents for chemotherapy-related anemia and understanding their risks.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 14, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

New Approaches Needed for Peritoneal Metastases in CRC New Approaches Needed for Peritoneal Metastases in CRC
Dr David Kerr challenges the oncology community to come up with rational, meaningful clinical trials to clarify the biology of metastatic peritoneal disease in colorectal cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Antineoplastic Agents in Breast Cancers With Mutational Signatures Antineoplastic Agents in Breast Cancers With Mutational Signatures
Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Appropriate Use of Bone Scintigraphy to Diagnose Metastases Appropriate Use of Bone Scintigraphy to Diagnose Metastases
Beginning next year, clinicians will need to consult these new appropriate use criteria (AUC) for bone scintigraphy for bone metastases in cancer patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oncologists' Income in 2017 About the Same as Last Year Oncologists' Income in 2017 About the Same as Last Year
This year's Medscape Physician Compensation Report places US oncologists in about the middle of the pack compared to other specialists, with almost all respondents saying they made the right choice when selecting their specialty.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Increase in Childhood Cancer, but Survival Rates High Increase in Childhood Cancer, but Survival Rates High
The incidence of childhood cancers has increased in recent decades.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Local Consolidation Therapy for Oligometastatic NSCLC Local Consolidation Therapy for Oligometastatic NSCLC
Dr Jack West analyzes results of a provocative study testing local consolidation therapy in oligometastatic NSCLC, including how the results might guide clinical practice.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Individualize,' Says Prostate Cancer Screening From USPSTF'Individualize,' Says Prostate Cancer Screening From USPSTF
In an update to prostate screening guidance, the task force says that for men from 55 to 69 years of age, the decision to screen must be an individual one.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Value-Based Oncology Care an Imperfect Proposition Still Value-Based Oncology Care an Imperfect Proposition Still
ASCO said its value framework is still not ready for use, while a cancer center shared how it has implemented the Oncology Care Model, but has no data yet.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rice Bran, Bean Powder Might Reduce Colorectal Cancer Risk Rice Bran, Bean Powder Might Reduce Colorectal Cancer Risk
Diet supplemented with high-fiber rice bran and navy bean powder produces beneficial changes in the gut that might reduce colorectal cancer risk over time.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Gauging Appropriate Care for Older Breast Cancer Patients Gauging Appropriate Care for Older Breast Cancer Patients
Reviewing the latest clinical management tools, Dr Arti Hurria talks about caring for the geriatric oncology patient long-term, without burning out.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Long-Term Aspirin May Cut Risk for Cancer Death Long-Term Aspirin May Cut Risk for Cancer Death
Long-term, regular aspirin use was associated with a reduced relative risk for both death from any cause and from various cancers, in a big observational study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO Does Not Support'Right-to-Try' Laws ASCO Does Not Support'Right-to-Try' Laws
ASCO's all in favor of helping cancer patients gain better access to experimental drugs in their time of need, but not through'right-to-try'legislation, which they feel could be harmful.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news